On November 21, 2025, Ukrainian drones struck the Brom chemical plant in Krasnoperekopsk, occupied Crimea, hitting the only bromine producer of its kind in Eastern Europe. The attack severed a critical supply line for pharmaceutical manufacturing across the region.
Robert Brovdi, commander of Ukraine’s Unmanned Systems Forces and known as Madyar, confirmed the strike. “The birds of the USF visited the BROM chemical plant, which works for the occupier’s military-industrial complex,” Brovdi wrote on Telegram, publishing video footage from the attack.
What Brom Produces
The Brom plant specializes in bromine compounds used as brominating agents in manufacturing fine chemicals, pharmaceuticals, and pure metals. The facility produces sodium bromide, lithium bromide dihydrate, and iron trichloride—materials essential to pharmaceutical production.
Bromine derivatives serve as chemical intermediates in drug manufacturing. Without a reliable supply, pharmaceutical companies relying on the plant face production disruptions.
Nearly 600 people worked at the facility, making it one of the largest employers in Krasnoperekopsk. The plant had been operating under Russian occupation since 2014, when Russia annexed Crimea.
The Strike
Operators from the 14th Unmanned Systems Forces Regiment carried out the attack. Ukrainian drones approached the plant and struck multiple targets within the facility. Video footage shows explosions and fires breaking out at the complex.
Ukrainian forces also hit the Krasnoperekopsk substation during the same operation, a key hub in Crimea’s power grid. Brovdi noted that “a number of energy facilities in the occupied territories were blacked out” following the strikes on the nights of November 22 and 23.
Pharmaceutical Supply Disruption
The destruction of the Brom plant removes Eastern Europe’s only regional source of bromine compounds. Pharmaceutical manufacturers that relied on the facility will need to source materials from producers in Israel, the United States, or China—the world’s other major bromine suppliers.
The strike comes as both Ukraine and Russia have targeted pharmaceutical infrastructure throughout the war. Russia has destroyed multiple warehouses belonging to Optima-Pharm, Ukraine’s second-largest pharmaceutical distributor, causing over $100 million in losses in a single October 2025 attack. A third Optima-Pharm warehouse was destroyed in Dnipro in November, wiping out medicines supplying Ukraine’s southern regions.
The October attack on Optima-Pharm eliminated 20% of Ukraine’s monthly medicine stock. Ukraine’s Deputy Health Minister stated that the company activated reserve buffer warehouses to prevent shortages, but the repeated strikes have placed severe pressure on the country’s pharmaceutical logistics.
Strategic Impact
By targeting the Brom plant, Ukraine struck a facility that supplied Russia’s military-industrial complex while simultaneously disrupting pharmaceutical supply chains. The plant’s location in occupied Crimea made it a legitimate military target under international law, as it contributed to Russia’s war effort.
The pharmaceutical industry’s reliance on bromine compounds means the plant’s destruction will ripple beyond military applications. Companies dependent on Brom’s output will face higher costs and longer lead times as they shift to alternative suppliers.
Whether the plant can be rebuilt or restored to operation remains unclear. The extent of the damage has not been fully assessed, but the fires and explosions visible in drone footage suggest significant destruction to the facility’s production infrastructure.
